메뉴 건너뛰기




Volumn 381, Issue 9880, 2013, Pages 1855-1865

Alternatives to blood transfusion

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; DESMOPRESSIN; PROTHROMBIN COMPLEX;

EID: 84878068834     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60808-9     Document Type: Review
Times cited : (215)

References (105)
  • 1
    • 0037466923 scopus 로고    scopus 로고
    • Current and emerging infectious risks of blood transfusions
    • Busch MP, Kleinman SH, Nemo GJ Current and emerging infectious risks of blood transfusions. JAMA 2003; 289: 959-62.
    • (2003) JAMA , vol.289 , pp. 959-962
    • Busch, M.P.1    Kleinman, S.H.2    Nemo, G.J.3
  • 3
    • 80054699488 scopus 로고    scopus 로고
    • Preoperative anaemia and postoperative outcomes in non-cardiac surgery: A retrospective cohort study
    • Musallam KM, Tamim HM, Richards T, et al Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396-407.
    • (2011) Lancet , vol.378 , pp. 1396-1407
    • Musallam, K.M.1    Tamim, H.M.2    Richards, T.3
  • 4
    • 64949084201 scopus 로고    scopus 로고
    • Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients
    • Bernard AC, Davenport DL, Chang P.K., Vaughan TB, Zwischenberger JB Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg 2009; 208: 931-37.
    • (2009) J Am Coll Surg , vol.208 , pp. 931-937
    • Bernard, A.C.1    Davenport, D.L.2    Chang, P.K.3    Vaughan, T.B.4    Zwischenberger, J.B.5
  • 5
    • 0037174359 scopus 로고    scopus 로고
    • Anemia and blood transfusion in critically ill patients
    • Vincent JL, Baron JF, Reinhart K, et al Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-507.
    • (2002) JAMA , vol.288 , pp. 1499-1507
    • Vincent, J.L.1    Baron, J.F.2    Reinhart, K.3
  • 6
    • 84864042696 scopus 로고    scopus 로고
    • Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
    • Carson JL, Carless PA, Hebert PC Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 4: CD002042.
    • (2012) Cochrane Database Syst Rev , vol.4
    • Carson, J.L.1    Carless, P.A.2    Hebert, P.C.3
  • 7
    • 84876770704 scopus 로고    scopus 로고
    • Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration
    • Frank SM, Abazyan B, Ono M., et al Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration. Anesth Analg 2013; 116: 975-81.
    • (2013) Anesth Analg , vol.116 , pp. 975-981
    • Frank, S.M.1    Abazyan, B.2    Ono, M.3
  • 8
    • 84876479056 scopus 로고    scopus 로고
    • Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia
    • Solomon SB, Wang D, Sun J., et al Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia. Blood 2013; 121: 1663-72.
    • (2013) Blood , vol.121 , pp. 1663-1672
    • Solomon, S.B.1    Wang, D.2    Sun, J.3
  • 9
    • 65349166375 scopus 로고    scopus 로고
    • Transfusion-related mortality: The ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
    • Vamvakas EC, Blajchman MA Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113: 3406-17.
    • (2009) Blood , vol.113 , pp. 3406-3417
    • Vamvakas, E.C.1    Blajchman, M.A.2
  • 10
    • 79551552147 scopus 로고    scopus 로고
    • Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: Nata guidelines
    • Goodnough LT, Maniatis A, Earnshaw P., et al Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22.
    • (2011) Br J Anaesth , vol.106 , pp. 13-22
    • Goodnough, L.T.1    Maniatis, A.2    Earnshaw, P.3
  • 11
    • 78651377892 scopus 로고    scopus 로고
    • Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty
    • Na HS, Shin SY, Hwang J.Y., Jeon YT, Kim CS, Do SH Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion 2011; 51: 118-24.
    • (2011) Transfusion , vol.51 , pp. 118-124
    • Na, H.S.1    Shin, S.Y.2    Hwang, J.Y.3    Jeon, Y.T.4    Kim, C.S.5    Do, S.H.6
  • 12
    • 80055016788 scopus 로고    scopus 로고
    • Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery
    • Yoo YC, Shim JK, Kim J.C., Jo YY, Lee JH, Kwak YL Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology 2011; 115: 929-37.
    • (2011) Anesthesiology , vol.115 , pp. 929-937
    • Yoo, Y.C.1    Shim, J.K.2    Kim, J.C.3    Jo, Y.Y.4    Lee, J.H.5    Kwak, Y.L.6
  • 13
    • 79952197748 scopus 로고    scopus 로고
    • Transfusion in trauma: Thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy
    • Schochl H, Nienaber U, Maegele M., et al Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15: R83.
    • (2011) Crit Care , vol.15
    • Schochl, H.1    Nienaber, U.2    Maegele, M.3
  • 14
    • 84861379621 scopus 로고    scopus 로고
    • Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: A quality improvement cycle
    • Kotze A, Carter LA, Scally AJ Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth 2012; 108: 943-52.
    • (2012) Br J Anaesth , vol.108 , pp. 943-952
    • Kotze, A.1    Carter, L.A.2    Scally, A.J.3
  • 15
    • 84862889184 scopus 로고    scopus 로고
    • Point-of-care testing: A prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients
    • Weber CF, Gorlinger K, Meininger D., et al Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-47.
    • (2012) Anesthesiology , vol.117 , pp. 531-547
    • Weber, C.F.1    Gorlinger, K.2    Meininger, D.3
  • 16
    • 84871544047 scopus 로고    scopus 로고
    • Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: A randomized, placebo-controlled trial
    • Rahe-Meyer N., Solomon C, Hanke A., et al Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 2013; 118: 40-50.
    • (2013) Anesthesiology , vol.118 , pp. 40-50
    • Rahe-Meyer, N.1    Solomon, C.2    Hanke, A.3
  • 20
    • 78649753411 scopus 로고    scopus 로고
    • Detection, evaluation, and management of iron-restricted erythropoiesis
    • Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010; 116: 4754-61.
    • (2010) Blood , vol.116 , pp. 4754-4761
    • Goodnough, L.T.1    Nemeth, E.2    Ganz, T.3
  • 21
    • 84863807852 scopus 로고    scopus 로고
    • Iron deficiency syndromes and iron-restricted erythropoiesis
    • Goodnough LT. Iron deficiency syndromes and iron-restricted erythropoiesis. Transfusion 2012; 52: 1584-92.
    • (2012) Transfusion , vol.52 , pp. 1584-1592
    • Goodnough, L.T.1
  • 23
    • 79951972309 scopus 로고    scopus 로고
    • 2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines
    • Ferraris VA, Brown JR, Despotis G.J., et al 2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-82.
    • (2011) Ann Thorac Surg , vol.91 , pp. 944-982
    • Ferraris, V.A.1    Brown, J.R.2    Despotis, G.J.3
  • 24
    • 70449503461 scopus 로고    scopus 로고
    • An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: Safety analysis
    • Stowell CP, Jones SC, Enny C, Langholff W, Leitz G. An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: safety analysis. Spine 2009; 34: 2479-85.
    • (2009) Spine , vol.34 , pp. 2479-2485
    • Stowell, C.P.1    Jones, S.C.2    Enny, C.3    Langholff, W.4    Leitz, G.5
  • 25
    • 0031036078 scopus 로고    scopus 로고
    • Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery
    • Sowade O, Warnke H, Scigalla P., et al Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997; 89: 411-18.
    • (1997) Blood , vol.89 , pp. 411-418
    • Sowade, O.1    Warnke, H.2    Scigalla, P.3
  • 26
    • 76749134292 scopus 로고    scopus 로고
    • Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: A randomized blind controlled study
    • Weltert L, D'Alessandro S, Nardella S, et al Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg 2010; 139: 621-26.
    • (2010) J Thorac Cardiovasc Surg , vol.139 , pp. 621-626
    • Weltert, L.1    D'Alessandro, S.2    Nardella, S.3
  • 27
    • 0031406905 scopus 로고    scopus 로고
    • Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients
    • D'Ambra M.N., Gray RJ, Hillman R, et al Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg 1997; 64: 1686-93.
    • (1997) Ann Thorac Surg , vol.64 , pp. 1686-1693
    • D'Ambra, M.N.1    Gray, R.J.2    Hillman, R.3
  • 28
    • 0037406140 scopus 로고    scopus 로고
    • Bloodless medicine: Clinical care without allogeneic blood transfusion
    • Goodnough LT, Shander A, Spence R. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion 2003; 43: 668-76.
    • (2003) Transfusion , vol.43 , pp. 668-676
    • Goodnough, L.T.1    Shander, A.2    Spence, R.3
  • 30
    • 0035686187 scopus 로고    scopus 로고
    • The rise and fall of preoperative autologous blood donation
    • Brecher ME, Goodnough LT The rise and fall of preoperative autologous blood donation. Transfusion 2001; 41: 1459-62.
    • (2001) Transfusion , vol.41 , pp. 1459-1462
    • Brecher, M.E.1    Goodnough, L.T.2
  • 31
    • 0036704235 scopus 로고    scopus 로고
    • A prospective, randomized study of preoperative autologous donation for hip replacement surgery
    • Billote DB, Glisson SN, Green D, Wixson RL A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 2002; 84: 1299-304.
    • (2002) J Bone Joint Surg Am , vol.84 , pp. 1299-1304
    • Billote, D.B.1    Glisson, S.N.2    Green, D.3    Wixson, R.L.4
  • 32
    • 74849123956 scopus 로고    scopus 로고
    • Acute normovolemic hemodilution is not beneficial in patients undergoing primary elective valve surgery
    • Virmani S, Tempe DK, Pandey B.C., et al Acute normovolemic hemodilution is not beneficial in patients undergoing primary elective valve surgery. Ann Card Anaesth 2010; 13: 34-38.
    • (2010) Ann Card Anaesth , vol.13 , pp. 34-38
    • Virmani, S.1    Tempe, D.K.2    Pandey, B.C.3
  • 33
    • 0027018429 scopus 로고
    • A controlled trial of intra-operative autologous transfusion in cardiothoracic surgery measuring effect on transfusion requirements and clinical outcome
    • Bell K, Stott K, Sinclair C.J., Walker WS, Gillon J. A controlled trial of intra-operative autologous transfusion in cardiothoracic surgery measuring effect on transfusion requirements and clinical outcome. Transfus Med 1992; 2: 295-300.
    • (1992) Transfus Med , vol.2 , pp. 295-300
    • Bell, K.1    Stott, K.2    Sinclair, C.J.3    Walker, W.S.4    Gillon, J.5
  • 34
    • 84876132629 scopus 로고    scopus 로고
    • Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: Results of a randomized comparison
    • Weltert L, Nardella S, Rondinelli M.B., Pierelli L., De Paulis R. Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison. Transfusion 2013; 53: 790-97.
    • (2013) Transfusion , vol.53 , pp. 790-797
    • Weltert, L.1    Nardella, S.2    Rondinelli, M.B.3    Pierelli, L.4    De Paulis, R.5
  • 36
    • 2942716858 scopus 로고    scopus 로고
    • Desmopressin for minimising perioperative allogeneic blood transfusion
    • Carless PA, Henry DA, Moxey A.J., et al Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2004; 1: CD001884.
    • (2004) Cochrane Database Syst Rev , vol.1
    • Carless, P.A.1    Henry, D.A.2    Moxey, A.J.3
  • 37
    • 58149300170 scopus 로고    scopus 로고
    • Desmopressin reduces transfusion needs after surgery: A meta-analysis of randomized clinical trials
    • Crescenzi G, Landoni G, Biondi-Zoccai G, et al Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. Anesthesiology 2008; 109: 1063-76.
    • (2008) Anesthesiology , vol.109 , pp. 1063-1076
    • Crescenzi, G.1    Landoni, G.2    Biondi-Zoccai, G.3
  • 38
    • 79955375429 scopus 로고    scopus 로고
    • Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion
    • Steinlechner B, Zeidler P, Base E., et al Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Ann Thorac Surg 2011; 91: 1420-26.
    • (2011) Ann Thorac Surg , vol.91 , pp. 1420-1426
    • Steinlechner, B.1    Zeidler, P.2    Base, E.3
  • 39
    • 0345167849 scopus 로고    scopus 로고
    • Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin
    • Reiter RA, Mayr F, Blazicek H., et al Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. Blood 2003; 102: 4594-99.
    • (2003) Blood , vol.102 , pp. 4594-4599
    • Reiter, R.A.1    Mayr, F.2    Blazicek, H.3
  • 41
    • 81855194434 scopus 로고    scopus 로고
    • First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A retrospective, single-center cohort study
    • Gorlinger K, Dirkmann D, Hanke A.A., et al First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011; 115: 1179-91.
    • (2011) Anesthesiology , vol.115 , pp. 1179-1191
    • Gorlinger, K.1    Dirkmann, D.2    Hanke, A.A.3
  • 42
    • 84867281693 scopus 로고    scopus 로고
    • Risks of harms using antifibrinolytics in cardiac surgery: Systematic review and network meta-analysis of randomised and observational studies
    • Hutton B, Joseph L, Fergusson D., Mazer CD, Shapiro S, Tinmouth A. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. BMJ 2012; 345: e5798.
    • (2012) BMJ , vol.345
    • Hutton, B.1    Joseph, L.2    Fergusson, D.3    Mazer, C.D.4    Shapiro, S.5    Tinmouth, A.6
  • 43
    • 44349089188 scopus 로고    scopus 로고
    • A comparison of aprotinin and lysine analogues in high-risk cardiac surgery
    • Fergusson DA, Hebert PC, Mazer C.D., et al A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358: 2319-31.
    • (2008) N Engl J Med , vol.358 , pp. 2319-2331
    • Fergusson, D.A.1    Hebert, P.C.2    Mazer, C.D.3
  • 44
    • 84871949260 scopus 로고    scopus 로고
    • Current status of pharmacologic therapies in patient blood management
    • Goodnough LT, Shander A. Current status of pharmacologic therapies in patient blood management. Anesth Analg 2013; 116: 15-34.
    • (2013) Anesth Analg , vol.116 , pp. 15-34
    • Goodnough, L.T.1    Shander, A.2
  • 45
    • 79952270874 scopus 로고    scopus 로고
    • Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
    • Henry DA, Carless PA, Moxey A.J., et al Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; 3: CD001886.
    • (2011) Cochrane Database Syst Rev , vol.3
    • Henry, D.A.1    Carless, P.A.2    Moxey, A.J.3
  • 46
    • 84861503406 scopus 로고    scopus 로고
    • Effect of tranexamic acid on surgical bleeding: Systematic review and cumulative meta-analysis
    • Ker K, Edwards P, Perel P., Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012; 344: e3054.
    • (2012) BMJ , vol.344
    • Ker, K.1    Edwards, P.2    Perel, P.3    Shakur, H.4    Roberts, I.5
  • 47
    • 79953163189 scopus 로고    scopus 로고
    • The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial
    • Roberts I, Shakur H, Afolabi A., et al The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096-101.
    • (2011) Lancet , vol.377 , pp. 1096-1101
    • Roberts, I.1    Shakur, H.2    Afolabi, A.3
  • 48
    • 50449098285 scopus 로고    scopus 로고
    • Mechanisms of thrombus formation
    • Furie B, Furie BC Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-49.
    • (2008) N Engl J Med , vol.359 , pp. 938-949
    • Furie, B.1    Furie, B.C.2
  • 49
    • 84876280594 scopus 로고    scopus 로고
    • Management of bleeding and coagulopathy following major trauma: An updated european guideline
    • Spahn DR, Bouillon B, Cerny V., et al Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013, 17: R76.
    • (2013) Crit Care , vol.17
    • Spahn, D.R.1    Bouillon, B.2    Cerny, V.3
  • 50
    • 84865482138 scopus 로고    scopus 로고
    • Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: Experience with 1974 consecutive trauma patients
    • Holcomb JB, Minei KM, Scerbo M.L., et al Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012; 256: 476-86.
    • (2012) Ann Surg , vol.256 , pp. 476-486
    • Holcomb, J.B.1    Minei, K.M.2    Scerbo, M.L.3
  • 51
    • 84861451009 scopus 로고    scopus 로고
    • Association between fibrinogen level and severity of postpartum haemorrhage: Secondary analysis of a prospective trial
    • Cortet M, Deneux-Tharaux C, Dupont C., et al Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 2012; 108: 984-89.
    • (2012) Br J Anaesth , vol.108 , pp. 984-989
    • Cortet, M.1    Deneux-Tharaux, C.2    Dupont, C.3
  • 52
    • 80053959247 scopus 로고    scopus 로고
    • Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: A systematic review
    • Kozek-Langenecker S., Sorensen B, Hess J.R., Spahn DR Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care 2011; 15: R239.
    • (2011) Crit Care , vol.15
    • Kozek-Langenecker, S.1    Sorensen, B.2    Hess, J.R.3    Spahn, D.R.4
  • 53
    • 67749122125 scopus 로고    scopus 로고
    • Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study
    • Karlsson M, Ternstrom L, Hyllner M., et al Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009; 102: 137-44.
    • (2009) Thromb Haemost , vol.102 , pp. 137-144
    • Karlsson, M.1    Ternstrom, L.2    Hyllner, M.3
  • 54
    • 84874848540 scopus 로고    scopus 로고
    • Logistics of transfusion support for patients with massive hemorrhage
    • Goodnough LT, Spain DA, Maggio P. Logistics of transfusion support for patients with massive hemorrhage. Curr Opin Anaesthesiol 2013; 26: 208-14.
    • (2013) Curr Opin Anaesthesiol , vol.26 , pp. 208-214
    • Goodnough, L.T.1    Spain, D.A.2    Maggio, P.3
  • 55
    • 33846423913 scopus 로고    scopus 로고
    • Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography
    • Rugeri L, Levrat A, David J.S., et al Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007; 5: 289-95.
    • (2007) J Thromb Haemost , vol.5 , pp. 289-295
    • Rugeri, L.1    Levrat, A.2    David, J.S.3
  • 56
    • 79953280012 scopus 로고    scopus 로고
    • Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion
    • Afshari A, Wikkelso A, Brok J., Moller AM, Wetterslev J. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011; 3: CD007871.
    • (2011) Cochrane Database Syst Rev , vol.3
    • Afshari, A.1    Wikkelso, A.2    Brok, J.3    Moller, A.M.4    Wetterslev, J.5
  • 57
    • 84872773471 scopus 로고    scopus 로고
    • The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma
    • Innerhofer P, Westermann I, Tauber H., et al The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 2013; 44: 209-16.
    • (2013) Injury , vol.44 , pp. 209-216
    • Innerhofer, P.1    Westermann, I.2    Tauber, H.3
  • 58
    • 79953306391 scopus 로고    scopus 로고
    • Clinical review: Prothrombin complex concentrates - Evaluation of safety and thrombogenicity
    • Sorensen B, Spahn DR, Innerhofer P, Spannagl M., Rossaint R. Clinical review: prothrombin complex concentrates - evaluation of safety and thrombogenicity. Crit Care 2011; 15: R201.
    • (2011) Crit Care , vol.15
    • Sorensen, B.1    Spahn, D.R.2    Innerhofer, P.3    Spannagl, M.4    Rossaint, R.5
  • 59
    • 79959476160 scopus 로고    scopus 로고
    • How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage
    • Goodnough LT, Shander A. How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. Blood 2011; 117: 6091-99.
    • (2011) Blood , vol.117 , pp. 6091-6099
    • Goodnough, L.T.1    Shander, A.2
  • 60
    • 77954403042 scopus 로고    scopus 로고
    • Prothrombin complex concentrates: An update
    • Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus 2010; 8: 149-54.
    • (2010) Blood Transfus , vol.8 , pp. 149-154
    • Franchini, M.1    Lippi, G.2
  • 61
    • 84856699090 scopus 로고    scopus 로고
    • Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th edn: American college of chest physicians evidence-based clinical practice guidelines
    • Guyatt GH, Akl EA, Crowther M, Gutterman D.D., Schuunemann HJ Executive summary: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141 (suppl 2): 7-47.
    • (2012) Chest , vol.141 , Issue.SUPPL. 2 , pp. 7-47
    • Guyatt, G.H.1    Akl, E.A.2    Crowther, M.3    Gutterman, D.D.4    Schuunemann, H.J.5
  • 62
    • 79955406987 scopus 로고    scopus 로고
    • Off-label use of recombinant factor VIIa in U.S. Hospitals: Analysis of hospital records
    • Logan AC, Yank V, Stafford RS Off-Label Use of Recombinant Factor VIIa in U.S. Hospitals: Analysis of Hospital Records. Ann Intern Med 2011; 154: 516-22.
    • (2011) Ann Intern Med , vol.154 , pp. 516-522
    • Logan, A.C.1    Yank, V.2    Stafford, R.S.3
  • 63
    • 79955414221 scopus 로고    scopus 로고
    • Systematic review: Benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications
    • Yank V, Tuohy CV, Logan A.C., et al Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med 2011; 154: 529-40.
    • (2011) Ann Intern Med , vol.154 , pp. 529-540
    • Yank, V.1    Tuohy, C.V.2    Logan, A.C.3
  • 64
    • 78049498149 scopus 로고    scopus 로고
    • Safety of recombinant activated factor VII in randomized clinical trials
    • Levi M, Levy JH, Andersen H.F., Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010; 363: 1791-800.
    • (2010) N Engl J Med , vol.363 , pp. 1791-1800
    • Levi, M.1    Levy, J.H.2    Andersen, H.F.3    Truloff, D.4
  • 65
    • 84877705084 scopus 로고    scopus 로고
    • Biology of factor XIII and clinical manifestations of factor XIII deficiency
    • published online Aug 28. doi:10.1111/j.1537-2995.2012.03865.x
    • Levy JH, Greenberg C. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency. Transfusion 2012; published online Aug 28. doi:10.1111/j.1537-2995.2012.03865.x.
    • (2012) Transfusion
    • Levy, J.H.1    Greenberg, C.2
  • 66
    • 32544449648 scopus 로고    scopus 로고
    • Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation
    • Godje O, Gallmeier U, Schelian M., Grunewald M, Mair H. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006; 54: 26-33.
    • (2006) Thorac Cardiovasc Surg , vol.54 , pp. 26-33
    • Godje, O.1    Gallmeier, U.2    Schelian, M.3    Grunewald, M.4    Mair, H.5
  • 67
    • 0036284022 scopus 로고    scopus 로고
    • Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: Implications of a prospective study
    • Gerlach R, Tolle F, Raabe A., Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 2002; 33: 1618-23.
    • (2002) Stroke , vol.33 , pp. 1618-1623
    • Gerlach, R.1    Tolle, F.2    Raabe, A.3    Zimmermann, M.4    Siegemund, A.5    Seifert, V.6
  • 68
    • 61549127913 scopus 로고    scopus 로고
    • Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding
    • Korte WC, Szadkowski C, Gahler A., et al Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology 2009; 110: 239-45.
    • (2009) Anesthesiology , vol.110 , pp. 239-245
    • Korte, W.C.1    Szadkowski, C.2    Gahler, A.3
  • 69
    • 84861796622 scopus 로고    scopus 로고
    • Recombinant factor XIII: A safe and novel treatment for congenital factor XIII deficiency
    • Inbal A, Oldenburg J, Carcao M., Rosholm A, Tehranchi R, Nugent D. Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency. Blood 2012; 119: 5111-17.
    • (2012) Blood , vol.119 , pp. 5111-5117
    • Inbal, A.1    Oldenburg, J.2    Carcao, M.3    Rosholm, A.4    Tehranchi, R.5    Nugent, D.6
  • 70
    • 84868301417 scopus 로고    scopus 로고
    • Hemostats, sealants, and adhesives III: A new update as well as cost and regulatory considerations for components of the surgical toolbox
    • Spotnitz WD, Burks S. Hemostats, sealants, and adhesives III: a new update as well as cost and regulatory considerations for components of the surgical toolbox. Transfusion 2012; 52: 2243-55.
    • (2012) Transfusion , vol.52 , pp. 2243-2255
    • Spotnitz, W.D.1    Burks, S.2
  • 71
    • 81855185283 scopus 로고    scopus 로고
    • Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis
    • Singla NK, Gasparis AP, Ballard J.L., et al Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis. J Am Coll Surg 2011; 213: 722-27.
    • (2011) J Am Coll Surg , vol.213 , pp. 722-727
    • Singla, N.K.1    Gasparis, A.P.2    Ballard, J.L.3
  • 72
    • 84866490453 scopus 로고    scopus 로고
    • Haemorrhage control in severely injured patients
    • Gruen RL, Brohi K, Schreiber M., et al Haemorrhage control in severely injured patients. Lancet 2012; 380: 1099-108.
    • (2012) Lancet , vol.380 , pp. 1099-1108
    • Gruen, R.L.1    Brohi, K.2    Schreiber, M.3
  • 73
    • 70449728019 scopus 로고    scopus 로고
    • Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery
    • Nasso G, Piancone F, Bonifazi R., et al Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg 2009; 88: 1520-26.
    • (2009) Ann Thorac Surg , vol.88 , pp. 1520-1526
    • Nasso, G.1    Piancone, F.2    Bonifazi, R.3
  • 74
    • 79955958017 scopus 로고    scopus 로고
    • Hepcidin and iron regulation, 10 years later
    • Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011; 117: 4425-33.
    • (2011) Blood , vol.117 , pp. 4425-4433
    • Ganz, T.1
  • 75
    • 77953372800 scopus 로고    scopus 로고
    • Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias
    • Nemeth E. Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Adv Hematol 2010; 2010: 750643.
    • (2010) Adv Hematol , vol.2010 , pp. 750643
    • Nemeth, E.1
  • 76
    • 77954611973 scopus 로고    scopus 로고
    • Iron loading and overloading due to ineffective erythropoiesis
    • Tanno T, Miller JL Iron loading and overloading due to ineffective erythropoiesis. Adv Hematol 2010; 2010: 358283.
    • (2010) Adv Hematol , vol.2010 , pp. 358283
    • Tanno, T.1    Miller, J.L.2
  • 77
    • 34447120059 scopus 로고    scopus 로고
    • Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
    • Peyssonnaux C, Zinkernagel AS, Schuepbach R.A., et al Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 2007; 117: 1926-32.
    • (2007) J Clin Invest , vol.117 , pp. 1926-1932
    • Peyssonnaux, C.1    Zinkernagel, A.S.2    Schuepbach, R.A.3
  • 78
    • 14744278436 scopus 로고    scopus 로고
    • Anemia of chronic disease
    • Weiss G, Goodnough LT Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23.
    • (2005) N Engl J Med , vol.352 , pp. 1011-1023
    • Weiss, G.1    Goodnough, L.T.2
  • 79
    • 84872951347 scopus 로고    scopus 로고
    • Hepcidin levels predict non-responsiveness to oral iron therapy in patients with iron deficiency anemia
    • Bregman DB, Morris D, Koch T.A., He A., Goodnough LT Hepcidin levels predict non-responsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol 2013, 88: 97-101.
    • (2013) Am J Hematol , vol.88 , pp. 97-101
    • Bregman, D.B.1    Morris, D.2    Koch, T.A.3    He, A.4    Goodnough, L.T.5
  • 80
    • 0032572913 scopus 로고    scopus 로고
    • The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
    • Besarab A, Bolton WK, Browne J.K., et al The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339: 584-90.
    • (1998) N Engl J Med , vol.339 , pp. 584-590
    • Besarab, A.1    Bolton, W.K.2    Browne, J.K.3
  • 81
    • 33750983605 scopus 로고    scopus 로고
    • Correction of anemia with epoetin alfa in chronic kidney disease
    • Singh AK, Szczech L, Tang K.L., et al Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-98.
    • (2006) N Engl J Med , vol.355 , pp. 2085-2098
    • Singh, A.K.1    Szczech, L.2    Tang, K.L.3
  • 82
    • 33751002326 scopus 로고    scopus 로고
    • Normalization of hemoglobin level in patients with chronic kidney disease and anemia
    • Drueke TB, Locatelli F, Clyne N., et al Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006; 355: 2071-84.
    • (2006) N Engl J Med , vol.355 , pp. 2071-2084
    • Drueke, T.B.1    Locatelli, F.2    Clyne, N.3
  • 83
    • 70949108082 scopus 로고    scopus 로고
    • A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
    • Pfeffer MA, Burdmann EA, Chen C.Y., et al A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361: 2019-32.
    • (2009) N Engl J Med , vol.361 , pp. 2019-2032
    • Pfeffer, M.A.1    Burdmann, E.A.2    Chen, C.Y.3
  • 84
    • 0041627742 scopus 로고    scopus 로고
    • Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: A randomized, double-blind, placebo-controlled study
    • Hedenus M, Adriansson M, San Miguel J, et al Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study. Br J Haematol 2003; 122: 394-403.
    • (2003) Br J Haematol , vol.122 , pp. 394-403
    • Hedenus, M.1    Adriansson, M.2    San Miguel, J.3
  • 85
    • 24944454286 scopus 로고    scopus 로고
    • Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
    • Leyland-Jones B., Semiglazov V, Pawlicki M., et al Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 2005; 23: 5960-72.
    • (2005) J Clin Oncol , vol.23 , pp. 5960-5972
    • Leyland-Jones, B.1    Semiglazov, V.2    Pawlicki, M.3
  • 86
    • 80052414508 scopus 로고    scopus 로고
    • PREPARE trial: A randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel +/- darbepoetin alfa in primary breast cancer-results at the time of surgery
    • Untch M, Fasching PA, Konecny G.E., et al PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel +/- darbepoetin alfa in primary breast cancer-results at the time of surgery. Ann Oncol 2011; 22: 1988-98.
    • (2011) Ann Oncol , vol.22 , pp. 1988-1998
    • Untch, M.1    Fasching, P.A.2    Konecny, G.E.3
  • 87
    • 0142186283 scopus 로고    scopus 로고
    • Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial
    • Henke M, Laszig R, Rube C., et al Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003; 362: 1255-60.
    • (2003) Lancet , vol.362 , pp. 1255-1260
    • Henke, M.1    Laszig, R.2    Rube, C.3
  • 88
    • 40549088086 scopus 로고    scopus 로고
    • Randomized study of the importance of novel erythropoiesis stimulating protein (Aranesp) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): The danish head and neck cancer group DAHANCA 10
    • abstract 6LB
    • Overgaard J, Hoff C, San Hansen H. Randomized study of the importance of novel erythropoiesis stimulating protein (Aranesp) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC): The Danish Head and Neck Cancer Group DAHANCA 10. Eur J Cancer 2007; 7 (suppl 5): abstract 6LB.
    • (2007) Eur J Cancer , vol.7 , Issue.SUPPL. 5
    • Overgaard, J.1    Hoff, C.2    San Hansen, H.3
  • 89
    • 38649128164 scopus 로고    scopus 로고
    • Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12·0 g/dL with erythropoietin vs above 10·0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer
    • Thomas G, Ali S, Hoebers F.J., et al Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12·0 g/dL with erythropoietin vs above 10·0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer. Gynecol Oncol 2008; 108: 317-25.
    • (2008) Gynecol Oncol , vol.108 , pp. 317-325
    • Thomas, G.1    Ali, S.2    Hoebers, F.J.3
  • 90
    • 34047221511 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
    • Wright JR, Ung YC, Julian J.A., et al Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol 2007; 25: 1027-32.
    • (2007) J Clin Oncol , vol.25 , pp. 1027-1032
    • Wright, J.R.1    Ung, Y.C.2    Julian, J.A.3
  • 91
    • 41949140285 scopus 로고    scopus 로고
    • Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
    • Smith RE J.r., Aapro MS, Ludwig H, et al Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. J Clin Oncol 2008; 26: 1040-50.
    • (2008) J Clin Oncol , vol.26 , pp. 1040-1050
    • Smith Jr., R.E.1    Aapro, M.S.2    Ludwig, H.3
  • 92
    • 65449117261 scopus 로고    scopus 로고
    • Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: A meta-analysis of randomised trials
    • Bohlius J, Schmidlin K, Brillant C., et al Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 2009; 373: 1532-42.
    • (2009) Lancet , vol.373 , pp. 1532-1542
    • Bohlius, J.1    Schmidlin, K.2    Brillant, C.3
  • 93
    • 70249134095 scopus 로고    scopus 로고
    • Erythroid-stimulating agents in cancer therapy: Potential dangers and biologic mechanisms
    • Hadland BK, Longmore GD Erythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanisms. J Clin Oncol 2009; 27: 4217-26.
    • (2009) J Clin Oncol , vol.27 , pp. 4217-4226
    • Hadland, B.K.1    Longmore, G.D.2
  • 94
    • 77953629597 scopus 로고    scopus 로고
    • Absence of functional EpoR expression in human tumor cell lines
    • Swift S, Ellison AR, Kassner P, et al Absence of functional EpoR expression in human tumor cell lines. Blood 2010; 115: 4254-63.
    • (2010) Blood , vol.115 , pp. 4254-4263
    • Swift, S.1    Ellison, A.R.2    Kassner, P.3
  • 95
    • 77952172809 scopus 로고    scopus 로고
    • Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells
    • Sinclair AM, Coxon A, McCaffery I., et al Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells. Blood 2010; 115: 4264-72.
    • (2010) Blood , vol.115 , pp. 4264-4272
    • Sinclair, A.M.1    Coxon, A.2    McCaffery, I.3
  • 96
    • 78549286047 scopus 로고    scopus 로고
    • American society of hematology/American society of clinical oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
    • Rizzo JD, Brouwers M, Hurley P., et al American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood 2010; 116: 4045-59.
    • (2010) Blood , vol.116 , pp. 4045-4059
    • Rizzo, J.D.1    Brouwers, M.2    Hurley, P.3
  • 97
    • 84871558330 scopus 로고    scopus 로고
    • KDIGO clinical practice guideline for anemia in chronic kidney disease
    • Kidney Disease: Improving Global Outcomes
    • Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2012; 2: 311-16.
    • (2012) Kidney Int Suppl , vol.2 , pp. 311-316
  • 98
    • 74849088872 scopus 로고    scopus 로고
    • Erythropoiesis-stimulating agents: Time for a reevaluation
    • Unger EF, Thompson AM, Blank M.J., Temple R. Erythropoiesis-stimulating agents: time for a reevaluation. N Engl J Med 2010; 362: 189-92.
    • (2010) N Engl J Med , vol.362 , pp. 189-192
    • Unger, E.F.1    Thompson, A.M.2    Blank, M.J.3    Temple, R.4
  • 99
    • 77958615383 scopus 로고    scopus 로고
    • Erythropoiesis stimulating agents, blood transfusion, and the practice of medicine
    • Goodnough LT, Shander AS Erythropoiesis stimulating agents, blood transfusion, and the practice of medicine. Am J Hematol 2010; 85: 835-37.
    • (2010) Am J Hematol , vol.85 , pp. 835-837
    • Goodnough, L.T.1    Shander, A.S.2
  • 100
    • 84875500204 scopus 로고    scopus 로고
    • Treatment of anemia with darbepoetin alfa in systolic heart failure
    • Swedberg K, Young JB, Anand I.S., et al Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 2013; 368: 1210-19.
    • (2013) N Engl J Med , vol.368 , pp. 1210-1219
    • Swedberg, K.1    Young, J.B.2    Anand, I.S.3
  • 101
    • 0025356824 scopus 로고
    • Diagnosis of iron-deficiency anemia in the elderly
    • Guyatt GH, Patterson C, Ali M., et al Diagnosis of iron-deficiency anemia in the elderly. Am J Med 1990; 88: 205-09.
    • (1990) Am J Med , vol.88 , pp. 205-209
    • Guyatt, G.H.1    Patterson, C.2    Ali, M.3
  • 102
    • 4944261763 scopus 로고    scopus 로고
    • Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia
    • Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein H.G., Woodman RC Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104: 2263-68.
    • (2004) Blood , vol.104 , pp. 2263-2268
    • Guralnik, J.M.1    Eisenstaedt, R.S.2    Ferrucci, L.3    Klein, H.G.4    Woodman, R.C.5
  • 103
    • 34447635386 scopus 로고    scopus 로고
    • What proportion of patients referred to secondary care with iron deficiency anemia have colon cancer?
    • Raje D, Mukhtar H, Oshowo A., Ingham Clark C. What proportion of patients referred to secondary care with iron deficiency anemia have colon cancer? Dis Colon Rectum 2007; 50: 1211-14.
    • (2007) Dis Colon Rectum , vol.50 , pp. 1211-1214
    • Raje, D.1    Mukhtar, H.2    Oshowo, A.3    Ingham Clark, C.4
  • 104
    • 33847046008 scopus 로고    scopus 로고
    • Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy
    • Henry DH, Dahl NV, Auerbach M, Tchekmedyian S., Laufman LR Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. Oncologist 2007; 12: 231-42.
    • (2007) Oncologist , vol.12 , pp. 231-242
    • Henry, D.H.1    Dahl, N.V.2    Auerbach, M.3    Tchekmedyian, S.4    Laufman, L.R.5
  • 105
    • 84878062805 scopus 로고    scopus 로고
    • Does plasma therapy have a role in clincial medicine?
    • (in press)
    • Goodnough LT. Does plasma therapy have a role in clincial medicine? Crit Care Med (in press).
    • Crit Care Med
    • Goodnough, L.T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.